Artificial Intelligence (AI) is significantly transforming the healthcare industry, altering how care is delivered, experienced, and managed. As medical institutions worldwide strive for more effective and efficient service delivery, AI emerges as a pivotal force driving innovation and
Achieving the first FDA approval for moderate-to-severe chronic hand eczema (CHE), LEO Pharma's Anzupgo cream marks a pivotal development in dermatological treatments. Chronic hand eczema presents formidable challenges, affecting a significant portion of the adult population with its persistent
In the realm of biopharmaceutical innovation, Ivan Kairatov stands as a distinguished figure, renowned for his expertise in research and development within the industry. Today, we delve into the groundbreaking approval by the European Commission of Darzalex for treating high-risk smouldering
The approval of Roche’s Itovebi marks a pivotal moment in breast cancer care, with the potential to significantly alter treatment strategies for ER-positive, HER2-negative breast cancer patients with PIK3CA mutations. The regulatory green light indicates a promising shift in oncology, specifically
In the world of biopharmaceuticals and immunotherapy, Ivan Kairatov stands out with his profound expertise. His deep understanding of the latest advancements makes him a perfect candidate to discuss ALK’s Itulazax, a groundbreaking treatment for hay fever caused by birch tree pollen. In this
A transformative wave is sweeping through biomedical science as the regenerative organs market is poised for unprecedented growth, with projections estimating it will reach a valuation of USD 225.18 billion by 2032. This anticipated growth is driven by a compelling combination of factors, most
